協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/08/22 | 1,486 | 1,502 | 1,468 | 1,478 | ±0 | ±0% | 1,172,100 |
2016/08/19 | 1,507 | 1,514 | 1,465 | 1,478 | -29 | -1.9% | 1,972,100 |
2016/08/18 | 1,558 | 1,561 | 1,504 | 1,507 | -50 | -3.2% | 1,558,300 |
2016/08/17 | 1,564 | 1,569 | 1,541 | 1,557 | -26 | -1.6% | 1,470,800 |
2016/08/16 | 1,621 | 1,626 | 1,583 | 1,583 | -34 | -2.1% | 1,413,700 |
2016/08/15 | 1,633 | 1,634 | 1,614 | 1,617 | -37 | -2.2% | 664,500 |
2016/08/12 | 1,653 | 1,662 | 1,633 | 1,654 | +24 | +1.5% | 1,431,500 |
2016/08/10 | 1,639 | 1,648 | 1,617 | 1,630 | -22 | -1.3% | 1,409,200 |
2016/08/09 | 1,631 | 1,663 | 1,621 | 1,652 | -2 | -0.1% | 1,688,600 |
2016/08/08 | 1,675 | 1,687 | 1,637 | 1,654 | -10 | -0.6% | 823,300 |
2016/08/05 | 1,680 | 1,686 | 1,648 | 1,664 | -35 | -2.1% | 1,354,700 |
2016/08/04 | 1,711 | 1,721 | 1,688 | 1,699 | -1 | -0.1% | 1,779,300 |
2016/08/03 | 1,715 | 1,729 | 1,698 | 1,700 | -49 | -2.8% | 1,299,200 |
2016/08/02 | 1,741 | 1,772 | 1,730 | 1,749 | -15 | -0.9% | 1,091,600 |
2016/08/01 | 1,771 | 1,793 | 1,737 | 1,764 | -39 | -2.2% | 1,603,800 |
2016/07/29 | 1,782 | 1,813 | 1,763 | 1,803 | -8 | -0.4% | 1,990,700 |
2016/07/28 | 1,865 | 1,869 | 1,800 | 1,811 | -77 | -4.1% | 1,375,200 |
2016/07/27 | 1,920 | 1,926 | 1,884 | 1,888 | -28 | -1.5% | 1,211,100 |
2016/07/26 | 1,916 | 1,935 | 1,905 | 1,916 | -11 | -0.6% | 956,400 |
2016/07/25 | 1,909 | 1,954 | 1,893 | 1,927 | +24 | +1.3% | 1,124,500 |
2016/07/22 | 1,930 | 1,950 | 1,875 | 1,903 | -25 | -1.3% | 1,214,100 |
2016/07/21 | 1,941 | 1,950 | 1,914 | 1,928 | +2 | +0.1% | 1,501,700 |
2016/07/20 | 1,891 | 1,936 | 1,891 | 1,926 | +42 | +2.2% | 2,220,200 |
2016/07/19 | 1,808 | 1,889 | 1,786 | 1,884 | +99 | +5.5% | 2,089,200 |
2016/07/15 | 1,822 | 1,829 | 1,781 | 1,785 | -30 | -1.7% | 953,600 |
2016/07/14 | 1,764 | 1,820 | 1,755 | 1,815 | +50 | +2.8% | 1,113,000 |
2016/07/13 | 1,839 | 1,843 | 1,750 | 1,765 | -77 | -4.2% | 2,111,900 |
2016/07/12 | 1,850 | 1,871 | 1,837 | 1,842 | +22 | +1.2% | 1,085,800 |
2016/07/11 | 1,807 | 1,836 | 1,807 | 1,820 | +51 | +2.9% | 1,204,000 |
2016/07/08 | 1,841 | 1,841 | 1,761 | 1,769 | -65 | -3.5% | 2,480,600 |
2016/07/07 | 1,850 | 1,852 | 1,814 | 1,834 | +92 | +5.3% | 2,508,300 |
2016/07/06 | 1,712 | 1,745 | 1,705 | 1,742 | +4 | +0.2% | 1,055,400 |
2016/07/05 | 1,738 | 1,743 | 1,724 | 1,738 | -2 | -0.1% | 753,900 |
2016/07/04 | 1,726 | 1,746 | 1,712 | 1,740 | +14 | +0.8% | 976,400 |
2016/07/01 | 1,731 | 1,741 | 1,709 | 1,726 | -10 | -0.6% | 1,590,000 |
2016/06/30 | 1,778 | 1,782 | 1,719 | 1,736 | -39 | -2.2% | 2,012,300 |
2016/06/29 | 1,747 | 1,783 | 1,724 | 1,775 | +72 | +4.2% | 2,102,300 |
2016/06/28 | 1,653 | 1,720 | 1,634 | 1,703 | +9 | +0.5% | 1,248,700 |
2016/06/27 | 1,664 | 1,699 | 1,643 | 1,694 | +81 | +5% | 2,461,400 |
2016/06/24 | 1,759 | 1,765 | 1,590 | 1,613 | -146 | -8.3% | 2,489,300 |
2016/06/23 | 1,785 | 1,788 | 1,747 | 1,759 | -20 | -1.1% | 995,200 |
2016/06/22 | 1,792 | 1,799 | 1,758 | 1,779 | -31 | -1.7% | 1,095,300 |
2016/06/21 | 1,793 | 1,816 | 1,775 | 1,810 | +9 | +0.5% | 1,385,700 |
2016/06/20 | 1,825 | 1,839 | 1,795 | 1,801 | -6 | -0.3% | 1,381,700 |
2016/06/17 | 1,841 | 1,847 | 1,803 | 1,807 | +6 | +0.3% | 2,094,600 |
2016/06/16 | 1,869 | 1,886 | 1,795 | 1,801 | -72 | -3.8% | 1,161,900 |
2016/06/15 | 1,850 | 1,880 | 1,846 | 1,873 | +15 | +0.8% | 1,228,500 |
2016/06/14 | 1,900 | 1,903 | 1,842 | 1,858 | -44 | -2.3% | 1,189,200 |
2016/06/13 | 1,926 | 1,940 | 1,902 | 1,902 | -53 | -2.7% | 927,200 |
2016/06/10 | 1,982 | 1,988 | 1,941 | 1,955 | -11 | -0.6% | 1,782,900 |
2201~
2250
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.20倍 | 1.61倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム